WO2022068677A1 - 一种基于胸阻抗的运动肺功能测量系统 - Google Patents
一种基于胸阻抗的运动肺功能测量系统 Download PDFInfo
- Publication number
- WO2022068677A1 WO2022068677A1 PCT/CN2021/120106 CN2021120106W WO2022068677A1 WO 2022068677 A1 WO2022068677 A1 WO 2022068677A1 CN 2021120106 W CN2021120106 W CN 2021120106W WO 2022068677 A1 WO2022068677 A1 WO 2022068677A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thoracic impedance
- signal
- exercise
- pulmonary function
- measurement system
- Prior art date
Links
- 210000000115 thoracic cavity Anatomy 0.000 title claims abstract description 68
- 238000005259 measurement Methods 0.000 title claims abstract description 32
- 230000002685 pulmonary effect Effects 0.000 title abstract description 7
- 238000002847 impedance measurement Methods 0.000 claims abstract description 31
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 29
- 230000009325 pulmonary function Effects 0.000 claims abstract description 25
- 238000009423 ventilation Methods 0.000 claims abstract description 20
- 210000004072 lung Anatomy 0.000 claims abstract description 19
- 238000004891 communication Methods 0.000 claims abstract description 15
- 238000004590 computer program Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 21
- 238000009499 grossing Methods 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 16
- 230000008859 change Effects 0.000 claims description 14
- 230000004199 lung function Effects 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 11
- 230000002093 peripheral effect Effects 0.000 claims description 7
- 238000001514 detection method Methods 0.000 abstract description 7
- 210000002345 respiratory system Anatomy 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 10
- 239000002131 composite material Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000002564 cardiac stress test Methods 0.000 description 4
- 238000009613 pulmonary function test Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000013125 spirometry Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010013971 Dyspnoea exertional Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02438—Detecting, measuring or recording pulse rate or heart rate with portable devices, e.g. worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0809—Detecting, measuring or recording devices for evaluating the respiratory organs by impedance pneumography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/085—Measuring impedance of respiratory organs or lung elasticity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/091—Measuring volume of inspired or expired gases, e.g. to determine lung capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7225—Details of analog processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/725—Details of waveform analysis using specific filters therefor, e.g. Kalman or adaptive filters
Definitions
- the invention relates to the field of medical detection, in particular to a thoracic impedance-based exercise lung function measurement system.
- Cardiopulmonary exercise test is one of the pulmonary function tests commonly used in the world to measure the level of human respiratory and circulatory function. It can be used for the evaluation of functional exercise capacity, disease diagnosis, and judgment and treatment. Different from the static pulmonary function test, which only reflects the ventilation or ventilation status in the resting state, CPET firstly measures the whole set of pulmonary function of the human body in the resting state, and then continuously and dynamically monitors and records the in and out airflow, oxygen and carbon dioxide under different loads.
- Detecting the dynamic changes of parameters such as oxygen consumption and carbon dioxide excretion can reflect the patient's exercise limitation and exertional dyspnea in daily life, and can also be used for the prognosis evaluation of COPD patients.
- the measurement results are easily affected by the subject's test proficiency and auxiliary tools, which is not conducive to popularization.
- An exercise lung function measurement system based on thoracic impedance comprising a microcontroller, a wireless communication module, a thoracic impedance measurement module and a dedicated electrode array, the thoracic impedance measurement module is respectively connected to the dedicated electrode array and the microcontroller, and the miniature control The device is connected with the wireless communication module, wherein,
- the microcontroller invokes a pre-stored computer program to perform the following steps:
- the thoracic impedance measurement module includes a multiplexer switch, a human body impedance measurement chip, a self-calibration circuit and a peripheral circuit, and the human body impedance measurement chip is respectively connected to the multiplexer switch, the self-calibration circuit, the peripheral circuit and the microcontroller.
- the multiplexer switch is connected with the dedicated electrode array.
- de-interference processing includes the following steps:
- step 1) Subtract the signals obtained in step 1) and step 2), and perform smoothing processing to obtain a breathing signal during exercise.
- the anti-interference processing further includes: band-pass filtering the thoracic impedance signal to extract the heart rate signal.
- the smoothing in the steps 1) and 3) is implemented based on a five-point cubic smoothing filtering method.
- a small-amplitude pulse signal whose threshold value is less than the set value and represents the change of thoracic impedance caused by exercise is obtained from the signal obtained in step 1) as the human body. motion signal.
- the obtaining of local lung ventilation information and vital capacity information based on the breathing signal is specifically:
- the local lung ventilation and vital capacity are calculated according to the impedance-pulmonary ventilation fitting formula.
- Bioelectrical impedance technology refers to a detection technology that uses the electrical properties of biological tissues and organs and their changing laws to obtain biomedical information related to human physiological conditions. Due to the obvious differences in the electrical properties of lung tissue and gas in the lungs, the electrical impedance properties measured outside the human chest are sensitive to changes in the inflation state in the lungs. Therefore, the electrical impedance method can be used to detect changes in thoracic impedance in patients with pulmonary obstruction. This reflects the status of lung function.
- the electrical impedance method adopted in the present invention is simple to operate, safe and reliable, portable and wearable, and the subject does not need to pass the instrument to exhale and inhale, which is more easily accepted by the subject, and the patient cooperates. It has good performance and is suitable for monitoring the pulmonary ventilation status of patients in resting state or exercise state. Therefore, it can be used as an effective supplement to routine pulmonary function tests, and has important diagnostic value and clinical significance for early screening of COPD.
- the present invention is different from the exercise pulmonary function monitoring limited to the exercise of indoor equipment, and can monitor the pulmonary ventilation in indoor and outdoor exercise, diagnose the pulmonary function, and is convenient for use in daily exercise training, for the diagnosis of the pulmonary function. and treatment to provide reference information, with the following beneficial effects:
- the present invention uses AFE4300 chip to measure human body impedance. Compared with the human body impedance measurement system designed and realized by separate components, the integration degree is high, the volume of the measurement system is significantly reduced, and it is easy to wear. It needs to be hard-connected to a mobile phone or computer, so that lung function measurements can be performed during running, walking and other moving processes.
- the thoracic impedance data also includes measurement noise, motion noise, heartbeat and other information in addition to breathing information.
- the present invention adopts band-pass filtering, wavelet filtering, five-point cubic smoothing filtering, and polynomial fitting.
- motion noise, measurement noise, heartbeat noise, and baseline drift are removed from the measured thoracic impedance to obtain respiration-related signals, so that respiration-related thoracic impedance data can be extracted during exercise.
- the present invention processes the breathing-related thoracic impedance signal extracted during exercise, obtains local lung ventilation information and vital capacity information during exercise, and evaluates lung function, so that lung function evaluation based on thoracic impedance characteristics can be used for exercise. Pulmonary function tests were performed during the procedure.
- the present invention performs pulmonary function detection during non-fixed-point exercise, is wearable, has no disturbance to the subject's respiratory tract, no resistance increase, no risk of cross-infection, is more easily accepted by the subject, and is convenient for detection during daily fitness and training. use.
- Fig. 1 is the structural schematic diagram of the pulmonary function measurement system of the present invention
- Fig. 2 is the workflow schematic diagram of the present invention
- Figure 3 is an example of the waveform of the original sampled thoracic impedance signal
- Figure 4 is an example of an extracted heart rate signal
- Figure 5 is an example of a signal after filtering and smoothing and denoising
- Figure 7 is an example of the finally obtained signal related to human respiration.
- this embodiment provides a thoracic impedance-based exercise pulmonary function measurement system, including a microcontroller 1, a wireless communication module 2, a thoracic impedance measurement module 3, and a dedicated electrode array 4.
- the thoracic impedance measurement module 3 is respectively The dedicated electrode array 4 and the microcontroller 1 are connected, and the microcontroller 1 is connected with the wireless communication module 2 .
- the dedicated electrode array 4 is in contact with the surface of the human thoracic cavity, the thoracic impedance measurement module 3 collects the measurement voltage through the dedicated electrode array 4, and the microcontroller 1 controls the thoracic impedance measurement module 3 to perform self-calibration and thoracic impedance measurement process, and compare the measured thoracic impedance.
- Information processing obtains signals related to breathing, and then calculates the local lung ventilation status and vital capacity, and conducts lung function evaluation.
- the evaluation results can be transmitted to external devices (such as mobile phones, computers, etc.) through the wireless communication module 2.
- the chest impedance measurement module 3 includes a multiplexer switch 301, a body impedance measurement chip 302, a self-calibration circuit 301 and a peripheral circuit 304.
- the body impedance measurement chip 302 is respectively connected to the multiplexer switch 301, the self-calibration circuit 301, the peripheral circuit 304 and the micro
- the controller 1 and the multiplexer switch 301 are connected with the dedicated electrode array 4 to realize the measurement of different position information.
- the microcontroller controls the multiplexer switch, selects different electrode pairs in turn, applies the excitation current generated by the AFE4300 to the excitation electrode pair, and transmits the response voltage to the voltage measurement channel of the AFE4300 through the multiplexer switch, and measures in sequence.
- Four chest impedances upper left, upper right, lower left, and lower right.
- the human body impedance measurement chip 302 adopts the AFE4300 chip; the self-calibration circuit 301 includes a precision resistor and capacitor network, which is used to calibrate the measurement performance of the AFE4300; the peripheral circuit 304 is used to provide the AFE4300 with clock signals, parameter settings, etc. .
- the human body impedance measurement chip AFE4300 sequentially selects one of the four pairs of composite electrodes to the current excitation channel and voltage measurement channel of the AFE4300 through a multi-channel analog switch to perform impedance measurement.
- the microcontroller 1 invokes a pre-stored computer program to execute the following steps: acquiring the thoracic impedance signal collected by the thoracic impedance measuring module 3; performing de-interference processing on the thoracic impedance signal to acquire the breathing signal during exercise; obtaining local lung ventilation based on the breathing signal Information and spirometry information to achieve lung function assessment.
- the wireless communication module 2 adopts a Bluetooth communication module.
- the specific measurement process of the thoracic impedance-based exercise pulmonary function measurement system includes the following steps:
- the AFE4300 chip generates a 50kHz excitation current with an amplitude of 0.3500mA, and the current electrode pair in one of the four pairs of composite electrodes attached to the chest surface of the measured object is sequentially selected by the multiplexer switch to apply a weak current to the chest cavity of the human body. Excite the current, then measure the response voltage through the voltage electrode pair in the composite electrode, and obtain the thoracic impedance data according to the voltage/impedance fitting relationship obtained in step 1).
- the respiration signal s 0 (n) continuously monitored during exercise is obtained by an electrical impedance measurement system with a sampling rate of 128sps, that is, 128 samples per second.
- the original sampling signal is shown in Figure 3.
- the normal breathing rate of adults is 12-20 breaths/min at rest, and the normal heart rate is 60-100 breaths/min, which will increase during exercise.
- the thoracic impedance signal is subjected to wavelet filtering and smoothing, and the baseline drift is removed by polynomial fitting.
- the most general model of a measurement signal has the form:
- the smoothing used is a five-point cubic smoothing filtering method.
- the five-point cubic smoothing filter is a low-pass filter that uses polynomial least squares approximation to smooth the sampling points.
- the algorithm is as follows:
- a polynomial fitting method is used to remove the baseline drift.
- a polynomial fit is performed on a signal with a linear trend to obtain a fitted baseline, and then the baseline-fitted signal is subtracted from the original signal to obtain a signal with baseline drift removed.
- the present invention adopts the method of combining the above-mentioned wavelet threshold filtering and the five-point cubic smoothing method, which can effectively filter out high-frequency noise interference and maintain the reconstructed breathing signal to obtain a higher signal-to-noise ratio.
- the wavelet threshold filtering adopts a fixed hard threshold, which is adjusted according to the noise level estimation of the first layer of wavelet decomposition.
- the five-point cubic smoothing filter coefficient is 5, that is, 5 iterations are performed. At the same time, there is a certain baseline drift phenomenon in the measured signal.
- Threshold judgment is performed on the amplitude and slope changes of the obtained signal, and the human motion signal is extracted.
- the thoracic impedance value measured by the electrical impedance measurement system will change due to muscle movement and changes in the position of the diaphragm.
- the change of electrical impedance value caused by the change of air content in the lung is usually 2-10 ⁇ when the human body is breathing calmly, and the change of electrical impedance value caused by the change of air content in the lung during deep breathing is usually 5-20 ⁇ .
- the amplitude is small, usually below 2 ⁇ , and the increase and decrease are faster and the frequency is higher, which appears as a small-amplitude pulse signal superimposed on the breathing signal. Therefore, the resistance change s 3 (n) caused by the movement of the human body can be judged and extracted according to the threshold value and slope of the amplitude change, as shown in FIG. 6 .
- Subtracting s 2 (n) from s 3 (n) followed by a five-point cubic smoothing filter yields a breathing signal s 4 (n) that reflects lung ventilation conditions, as shown in FIG. 7 .
- a breathing signal s 4 (n) that reflects lung ventilation conditions, as shown in FIG. 7 .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Signal Processing (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Power Engineering (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
Claims (10)
- 一种基于胸阻抗的运动肺功能测量系统,其特征在于,包括微型控制器(1)、无线通信模块(2)、胸阻抗测量模块(3)和专用电极阵列(4),所述胸阻抗测量模块(3)分别连接专用电极阵列(4)和微型控制器(1),所述微型控制器(1)与无线通信模块(2)连接,其中,所述微型控制器(1)调用预存储的计算机程序执行以下步骤:获取胸阻抗测量模块(3)采集的胸阻抗信号;对所述胸阻抗信号进行去干扰处理,获取运动过程中的呼吸信号;基于所述呼吸信号获得局部肺通气信息和肺活量信息,实现肺功能评估。
- 根据权利要求1所述的基于胸阻抗的运动肺功能测量系统,其特征在于,所述胸阻抗测量模块(3)包括多路转换开关(301)、人体阻抗测量芯片(302)、自校正电路(301)和外围电路(304),所述人体阻抗测量芯片(302)分别连接多路转换开关(301)、自校正电路(301)、外围电路(304)和微型控制器(1),所述多路转换开关(301)与专用电极阵列(4)连接。
- 根据权利要求2所述的基于胸阻抗的运动肺功能测量系统,其特征在于,所述人体阻抗测量芯片(302)采用AFE4300芯片。
- 根据权利要求1所述的基于胸阻抗的运动肺功能测量系统,其特征在于,所述去干扰处理包括以下步骤:1)对所述胸阻抗信号进行小波滤波和平滑处理,并用多项式拟合法去除基线漂移;2)对步骤1)所得信号的幅值变化的阈值和斜率,提取人体运动信号;3)将步骤1)与步骤2)所得的信号相减,并做平滑处理,得到运动过程中的呼吸信号。
- 根据权利要求4所述的基于胸阻抗的运动肺功能测量系统,其特征在于,所述去干扰处理还包括:对所述胸阻抗信号进行带通滤波,提取心率信号。
- 根据权利要求5所述的基于胸阻抗的运动肺功能测量系统,其特征在于,基于巴特沃斯滤波器的带通滤波器实现所述带通滤波。
- 根据权利要求4所述的基于胸阻抗的运动肺功能测量系统,其特征在于, 所述步骤1)和步骤3)中的平滑处理基于五点三次平滑滤波方法实现。
- 根据权利要求4所述的基于胸阻抗的运动肺功能测量系统,其特征在于,所述步骤2)中,基于幅值变化的阈值和斜率,从步骤1)所得信号中获得阈值小于设定值的、表征运动产生的胸阻抗变化的小幅脉冲信号,作为所述人体运动信号。
- 根据权利要求1所述的基于胸阻抗的运动肺功能测量系统,其特征在于,所述基于所述呼吸信号获得局部肺通气信息和肺活量信息具体为:以所述呼吸信号作为准确胸阻抗信号,根据阻抗-肺通气量拟合公式,计算局部肺通气量和肺活量。
- 根据权利要求1所述的基于胸阻抗的运动肺功能测量系统,其特征在于,所述无线通信模块(2)采用蓝牙通信模块。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011047933.8 | 2020-09-29 | ||
CN202011047933.8A CN112022123B (zh) | 2020-09-29 | 2020-09-29 | 一种基于胸阻抗的运动肺功能测量系统 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022068677A1 true WO2022068677A1 (zh) | 2022-04-07 |
Family
ID=73572420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/120106 WO2022068677A1 (zh) | 2020-09-29 | 2021-09-24 | 一种基于胸阻抗的运动肺功能测量系统 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112022123B (zh) |
WO (1) | WO2022068677A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112022123B (zh) * | 2020-09-29 | 2021-08-06 | 上海交通大学 | 一种基于胸阻抗的运动肺功能测量系统 |
CN112842321B (zh) * | 2020-12-30 | 2022-05-20 | 上海交通大学 | 基于流量-容积环图的肺通气功能检测方法、设备及介质 |
EP4056114A1 (en) * | 2021-03-12 | 2022-09-14 | Onera Technologies B.V. | Method for extracting respiratory information from a bio-impedance signal |
CN115590497B (zh) * | 2022-07-29 | 2024-07-19 | 重庆大学 | 基于气-电同步测量的肺通气功能障碍疾病诊断系统 |
CN115211838A (zh) * | 2022-09-20 | 2022-10-21 | 深圳市健怡康医疗器械科技有限公司 | 基于耦合交互的肺功能检测的小型化智能设备 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101696791B1 (ko) * | 2015-07-31 | 2017-01-17 | 연세대학교 원주산학협력단 | 흉부임피던스를 이용한 폐기능 모니터링 장치 및 방법 |
CN109567805A (zh) * | 2017-09-29 | 2019-04-05 | 上海交通大学 | 基于胸阻抗测量的高性能肺功能检测系统及方法 |
CN110960210A (zh) * | 2019-12-13 | 2020-04-07 | 安徽通灵仿生科技有限公司 | 一种心肺功能监护仪 |
CN111012329A (zh) * | 2019-12-13 | 2020-04-17 | 安徽通灵仿生科技有限公司 | 一种高精度、运动型、无创便携式心肺功能参数测量设备 |
CN112022123A (zh) * | 2020-09-29 | 2020-12-04 | 上海交通大学 | 一种基于胸阻抗的运动肺功能测量系统 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IES20030467A2 (en) * | 2003-06-24 | 2005-02-09 | Univ Dublin | Methods for detecting sleep apnea using bioimpedance measurements |
ITPI20040060A1 (it) * | 2004-09-06 | 2004-12-06 | Smartex Srl | Metodo e apparato per il monitoraggio di variabili fisiologiche attraverso misure di mpedenza elettrica corporea |
CN202950655U (zh) * | 2012-12-07 | 2013-05-29 | 河南华南医电科技有限公司 | 胸阻抗测量电路 |
CN104305994B (zh) * | 2014-11-17 | 2017-05-31 | 重庆大学 | 心肺复苏中的胸阻抗信号处理方法 |
CN110996781A (zh) * | 2017-06-07 | 2020-04-10 | 呼吸运动公司 | 呼吸容积监测器和呼吸机 |
CN110974182A (zh) * | 2019-12-30 | 2020-04-10 | 中国科学院合肥物质科学研究院 | 一种基于生物电阻抗法的肌少症风险评估系统 |
-
2020
- 2020-09-29 CN CN202011047933.8A patent/CN112022123B/zh active Active
-
2021
- 2021-09-24 WO PCT/CN2021/120106 patent/WO2022068677A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101696791B1 (ko) * | 2015-07-31 | 2017-01-17 | 연세대학교 원주산학협력단 | 흉부임피던스를 이용한 폐기능 모니터링 장치 및 방법 |
CN109567805A (zh) * | 2017-09-29 | 2019-04-05 | 上海交通大学 | 基于胸阻抗测量的高性能肺功能检测系统及方法 |
CN110960210A (zh) * | 2019-12-13 | 2020-04-07 | 安徽通灵仿生科技有限公司 | 一种心肺功能监护仪 |
CN111012329A (zh) * | 2019-12-13 | 2020-04-17 | 安徽通灵仿生科技有限公司 | 一种高精度、运动型、无创便携式心肺功能参数测量设备 |
CN112022123A (zh) * | 2020-09-29 | 2020-12-04 | 上海交通大学 | 一种基于胸阻抗的运动肺功能测量系统 |
Also Published As
Publication number | Publication date |
---|---|
CN112022123B (zh) | 2021-08-06 |
CN112022123A (zh) | 2020-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022068677A1 (zh) | 一种基于胸阻抗的运动肺功能测量系统 | |
JP5416333B2 (ja) | 心臓データを取得するための装置及び方法 | |
US10945628B2 (en) | Apparatus and method for processing electromyography signals related to respiratory activity | |
CN109414204A (zh) | 用于确定针对对象的呼吸信息的方法和装置 | |
Prats-Boluda et al. | Active concentric ring electrode for non-invasive detection of intestinal myoelectric signals | |
JP5175834B2 (ja) | 呼吸でゲーティングされた心拍記録 | |
KR20180018581A (ko) | 관절 건강 평가를 위한 웨어러블 기술들 | |
CN112842321B (zh) | 基于流量-容积环图的肺通气功能检测方法、设备及介质 | |
US20160135715A1 (en) | Method for respiratory measurement | |
Berkebile et al. | Towards estimation of tidal volume and respiratory timings via wearable-patch-based impedance pneumography in ambulatory settings | |
KR101696791B1 (ko) | 흉부임피던스를 이용한 폐기능 모니터링 장치 및 방법 | |
RU2354285C1 (ru) | Способ акустического спектрального анализа обструктивных заболеваний легких | |
Fedotov et al. | Motion artifacts reduction in wearable respiratory monitoring device | |
CN116392104A (zh) | 一种基于多源信息去噪的胸阻抗测量方法及测量系统 | |
CN114027824B (zh) | 普适性肺通气量与经胸电阻抗的线性模型构建方法及应用 | |
KR20170037704A (ko) | 흉부임피던스를 측정을 위한 다중 전극 및 이를 이용한 흉부 임피던스 측정방법 | |
CN116269205A (zh) | 一种基于非接触心电的呼吸障碍评估系统及方法 | |
Kuo et al. | Using ECG surface electrodes in measurement of respiration rate for preterm infants | |
CN115397318A (zh) | 用于确定呼吸努力的系统和方法 | |
Blanco-Almazán et al. | The effect of walking on the estimation of breathing pattern parameters using wearable bioimpedance | |
US20220401059A1 (en) | Oral device for measuring respiratory sounds | |
Ochoa et al. | Development of an apnea detector for neonates using diaphragmatic surface electromyography | |
Popov et al. | Estimation of respiratory rate and heart rate during treadmill tests using acoustic sensor | |
Mäki-Karvia | Impedance pneumography in respiration monitoring | |
Gracia et al. | Multilead impedance pneumography and forced oscillation technique for assessing lung tissue mechanical properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21874338 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21874338 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21874338 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 28.09.2023) |